✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Blueprint Medicines Corp

Common Name
Blueprint Medicines
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
682
Ticker
BPMC
Exchange
NASDAQ/NGS
Description
Blueprint Medicines Corp. is a biopharmaceutical company focused on developing targeted therapies to treat genomically defined cancers, rare diseases, and cancer immunotherapy. The company's primary p...

Disclosures of Blueprint Medicines

Explore Blueprint Medicines's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Blueprint Medicines's official channels and fully traceable to its official company sources.

The table below lists all of Blueprint Medicines's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

If you want to search across Blueprint Medicines's' disclosures for specific data or insights, use our Disclosure Search.

NameReporting Period
Financial & Extra-Financial Disclosure
2024
10-K
2024
Financial & Extra-Financial Disclosure
2023
Annual Report
2023
Sustainability Report
2023
10-K
2022
Corporate Responsibility Report (CRR)
2022
10-K
2021
Corporate Responsibility Report (CRR)
2021
10-K
2020
10-K
2019
10-K
2018
10-K
2017
10-K
2016
10-K
2015
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?